Sheetal S. Buddhadev, Kevinkumar C. Garala
Sheetal S. Buddhadev1*, Kevinkumar C. Garala2
1Research Scholar, School of Pharmaceutical Sciences, Atmiya University, Rajkot, India, 360005.
2Professor, School of Pharmaceutical Sciences, Atmiya University, Rajkot, Gujarat, India 360005.
Volume - 16,
Issue - 10,
Year - 2023
Lipid-based drug delivery systems (LBDDS) are the most promising technique to formulate the poorly water soluble drugs. Nanotechnology strongly influences the therapeutic performance of hydrophobic drugs and has become an essential approach in drug delivery research. Self-Nanoemulsifying drug delivery systems (SNEDDS) are a vital strategy that combines benefits of LBDDS and nanotechnology. SNEDDS are now preferred to improve the formulation of drugs with poor aqueous solubility. SNEDDS are isotropic mixtures composed of oils, surfactants, and occasionally cosolvents. The ability of these formulations and methods to produce nanoemulsions or fine oil-in-water (o/w) emulsions after moderate stirring and dilution by water phase along the GI tract. SNEDDS has garnered attention during recent years as it improves oral bioavailability, reduces drug dose, and increases drug protection from unsuitable environment in the gastrointestinal tract. It can solve the problems related to the dissolution and bioavailability of the Biopharmaceutics Classifcation System Class II and IV drugs. This review shortly describes the ambiguity between nanoemulsions and microemulsions, mechanism of self-emulsifications, composition and function of various excipients of SNEDDS. This review discusses characterization of SNEDDS, advantage of SNEEDS over other emulsion, biopharmaceutical aspects, and limitation as well as future views. The SNEDDS is a potential formulation for drug delivery. Owing to its small particle size, large surface area, high encapsulation efficiency, and high drug loading, the SNEDDS can improve the rate and extent of oral absorption by maximizing drug solubility in the intestinal absorption site. Moreover, because of the lipid-based formulation of SNEDDS, it can stimulate and enhance lymphatic transport of drugs to avoid hepatic first-pass metabolism, and thus improve their bioavailability.
Cite this article:
Sheetal S. Buddhadev, Kevinkumar C. Garala. Self-Nano Emulsifying Drug Delivery System: A Potential Solution to the Challenges of Oral Delivery of Poorly Water-Soluble Drugs. Research Journal of Pharmacy and Technology 2023; 16(10):4943-1. doi: 10.52711/0974-360X.2023.00801
Sheetal S. Buddhadev, Kevinkumar C. Garala. Self-Nano Emulsifying Drug Delivery System: A Potential Solution to the Challenges of Oral Delivery of Poorly Water-Soluble Drugs. Research Journal of Pharmacy and Technology 2023; 16(10):4943-1. doi: 10.52711/0974-360X.2023.00801 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-10-71
1. Pouton CW. Formulation of poorly water- soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006; 29(2): 278– 287.
2. Rajpoot K., Tekade M., Pandey V., Nagaraja S., Youngren-Ortiz S.R., Tekade R.K. Self-microemulsifying drug-delivery system: Ongoing challenges and future ahead. In Drug Delivery Systems 2019; 393-454, Academic Press. https://doi.org /10.1016 /B978-0-12-814487-9.00009-0.
3. Mahmood, A.; Bernkop-Schnurch, A. SEDDS: A Game Changing Approach for the Oral Administration of Hydrophilic Macromolecular Drugs. Adv. Drug Deliv. Rev., 2019; 142(2): 91–101.
4. Uihelyi, Z.; Vecsernyes, M.; Feher, P.; Kosa, D.; Arany, P; et al. Physico-Chemical Characterization of Self-Emulsifying Drug Delivery Systems. Drug Discov. Today Technol. 2018; 27(3): 81–86.
5. Rajpoot, K.; Tekade, M.; Pandey, V.; Nagaraja, S.H.; Self-Microemulsifying Drug-Delivery System: Ongoing Challenges and Future Ahead. Drug Delivery Systems; Academic Press: Cambridge, MA, USA, 2020; 393–454.
6. Aristote,B.; Buya,; Beloqui A,; Memvanga P; Self-Nano-Emulsifying Drug-Delivery Systems: From the Development to the current Applications and Challenges in Oral Drug Delivery. Pharmaceutics 2020; 1194(12) :1-55.
7. Buya, A.B.; Ucakar, B.; Beloqui, A.; Memvanga, P.B.; Préat, V. Design and Evaluation of Self-Nanoemulsifying Drug Delivery Systems (SNEDDSs) for Senicapoc. Int. J. Pharm., 2020; 119180(3): 580-596.
8. Truong DH, Tran TH, Ramasamy T et al Development of solid self-emulsifying formulation for improving the oral bioavailability of erlotinib. AAPS PharmSciTech 2021; 17(1): 466–473. doi:https://doi. org/10.1208/s12249-015-0370-5
9. Valicherla GR, Dave KM, Syed AA et al Formulation optimization of docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti- tumor activity. Sci Rep 2016; 06(2): 268-85.doi: https://doi.org/ 10.1038/ srep26895
10. Singh B, Bandopadhyay S, Kapil R et al, Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit Rev Ther Drug Carr Syst 2009; 26(1) :427–451. Doi: https://doi.org/10.1615/ CritRevTherDrugCa rri erSyst.v26.i5.10
11. Rodriguez-Aller M, Guillarme D, Veuthey J- L, Gurny R Strategies for formulating and delivering poorly water-soluble drugs. J Drug Deliv Sci Technol. 2015; 30(4): 342– 351.doi:https://doi.org/10.1016/j. jddst.2015. 05.009
12. Tran, P., & Park, J.-S. Recent trends of self- emulsifying drug delivery system for enhancing the oral bioavailability of poorly water-soluble drugs. Journal of Pharmaceutical Investigation. 2021; 196- 218. doi:10.1007/s40005-021-00516-0
13. Kapilkumar Vithani, Vincent Jannin, Colin W. Pouton, Ben J. Boyd,Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water- soluble drugs, Advanced Drug Delivery Reviews. 2019; 142(1): 16-34. doi: https://doi.org/ 10.1016 / j.addr.2019;01.008.
14. Balakrishnan P, Lee B-J, Oh DH et al Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm. 2009; 374(2): 66–72. doi: https://doi.org/10.1016/j.ijpharm.2009;03.00 8
15. Das, S.S.; Singh, A.; Kar, S.; Ghosh, R.; Pal, M.; Fatima, M.; Singh, N.; Singh, S.K. Application of QbD Framework for Development of Self-Emulsifying Drug Delivery Systems. In Pharmaceutical Quality by Design; Academic Press: Cambridge, MA, USA, 2019; 297–330.
16. Fiza Ur Rehman, Kifayat Ullah Shah, Shefaat Ullah Shah, Ikram Ullah Khan, Gul Majid Khan & Amjad Khan: From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS), Expert Opinion on Drug Delivery. 2016; 1-15.
17. Julianto, T.; Yuen, K.H.; Noor, A.M. Improved Bioavailability of Vitamin E with a Self-Emulsifying Formulation. Int. J. Pharm. 2000; 200(2): 53–57.
18. Kamal, M.M.; Nazzal, S. Development of a new class of sulforaphane-enabled self- emulsifying drug delivery systems (SFN- SEDDS) by high through put screening: A case study with curcumin. Int. J. Pharm. 2018; 539(3): 147–156.
19. Postolache, P.; Petrescu, O.; Dorneanu, V.; Zanini, A.C. Cyclosporine Bioavailability of Two Physically Different Oral Formulations. Eur. Rev. Med. Pharmacol. Sci. 2002; 6(1): 127–131.
20. Yap, S.P.; Yuen, K.H. Influence of Lipolysis and Droplet Size on Tocotrienol Absorption from Self-Emulsifying Formulations. Int. J. Pharm. 2004; 281(1): 67–78.
21. Eltobshi A, Galal Mahmoud. Self-nanoemulsifying drug- delivery systems for potentiated anti- inflammatory activity of Diacerein, Int J Nanomedicine. 2018; 13(3): 6585-6602. doi: 10.2147/IJN.S178819.
22. Kang BK, Lee JS, Chon SK et al Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of Simvastatin in beagle dogs. Int J Pharm. 2004; 274(2): 65–73.doi: https://doi.org/10.1016/ j.ijpharm.2003.12.028.
23. El-Say, K.M.; Ahmed, T.A.; Ahmed, O.A.A. Self-Nanoemulsifying Lyophilized Tablets for Flash Oral Transmucosal Delivery of Vitamin K: Development and Clinical Evaluation. J. Pharm. Sci., 2017; 106(1): 2447–2456.
24. Batool A, Arshad R, Razzaq S, Nousheen K. Formulation and evaluation of hyaluronic acid-based mucoadhesive Self nanoemulsifying drug delivery system (SNEDDS) of Tamoxifen for targeting breast cancer. Int J Biol Macromol. 2020; 152(3): 503-515. DOI: 10.1016 /j.ijbiomac. 2020.02.275.
25. Mohammad Mahmoudian, Hadi Valizadeh, Raimar Lobenberg, et al. Enhancement of the intestinal absorption of Bortezomib by self- nanoemulsifying drug delivery system. Pharmaceutical Development and Technology. 2020; 25(3): 351-367.
26. Na YG, Byeon JJ, Wang M, Huh HW, Son GH, Jeon SH, Bang KH. Strategic approach to developing a Self-microemulsifying drug delivery system to enhance antiplatelet activity and bioavailability of Ticagrelor. Int J Nanomedicine. 2019; 15(14): 1193- 1212. DOI: 10.2147/IJN.S190426.
27. Nahla S Barakat, Enhanced oral bioavailability of Etodolac by self-emulsifying systems: in-vitro and in-vivo evaluation, Journal of Pharmacy and Pharmacology, 2010; 62(2): 173- 180.doi: https://doi.org/10.1211/jpp.62.02.0004.
28. Fang Lia, Rongfeng Hua, Bin Wanga, Yun Guia, Self-microemulsifying drug delivery system for improving the bioavailability of Huperzine A by lymphatic uptake. Acta- Pharmaceutica. 2017; 7(3) : 353-360. doi: http://dx.doi.org/ 10.1016/j.apsb.2017.02.002.